Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JACOB ALAN LEVY

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1710351515
CMS profile
11065831
Location
GLENDALE, NY

General Payments · PY2021–2024

$3,565.00

  • Reported across 155 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,453.81

59 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,453.81 59

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $298.84 13
Teva Pharmaceuticals USA, Inc. $289.88 11
Amgen Inc. $211.37 5
Lilly USA, LLC $210.11 9
Acerta Pharma LLC $121.51 6
Novo Nordisk AS $86.23 4
GlaxoSmithKline, LLC. $71.01 4
Abbott Laboratories $55.86 2
Astellas Pharma US Inc $46.26 2
PFIZER INC. $43.44 2
E.R. Squibb & Sons, L.L.C. $19.30 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $291.69 13
PY2022 $634.69 26
PY2023 $1,184.81 57
PY2024 $1,453.81 59

Payment records · PY2024 (59)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $26.15 06/04/2024 Food and Beverage Undisputed 01/23/2026 1125213177 CMS
Abbott Laboratories $29.71 07/15/2024 Food and Beverage Undisputed 01/23/2026 1125213179 CMS
ABBVIE INC. $23.80 01/18/2024 Food and Beverage Undisputed 01/23/2026 1107533335 CMS
ABBVIE INC. $22.69 01/29/2024 Food and Beverage Undisputed 01/23/2026 1107533337 CMS
ABBVIE INC. $23.64 02/20/2024 Food and Beverage Undisputed 01/23/2026 1107533339 CMS
ABBVIE INC. $25.11 03/25/2024 Food and Beverage Undisputed 01/23/2026 1107533341 CMS
ABBVIE INC. $20.23 04/02/2024 Food and Beverage Undisputed 01/23/2026 1107533343 CMS
ABBVIE INC. $15.60 05/13/2024 Food and Beverage Undisputed 01/23/2026 1107533345 CMS
ABBVIE INC. $27.50 05/22/2024 Food and Beverage Undisputed 01/23/2026 1107533347 CMS
ABBVIE INC. $33.95 06/24/2024 Food and Beverage Undisputed 01/23/2026 1107533349 CMS
ABBVIE INC. $34.93 07/18/2024 Food and Beverage Undisputed 01/23/2026 1107533351 CMS
ABBVIE INC. $22.29 08/07/2024 Food and Beverage Undisputed 01/23/2026 1107533353 CMS
ABBVIE INC. $20.93 09/25/2024 Food and Beverage Undisputed 01/23/2026 1107533355 CMS
ABBVIE INC. $20.71 10/30/2024 Food and Beverage Undisputed 01/23/2026 1107533357 CMS
ABBVIE INC. $7.46 12/11/2024 Food and Beverage Undisputed 01/23/2026 1107533359 CMS
Amgen Inc. $17.82 01/17/2024 Food and Beverage Undisputed 01/23/2026 1117610589 CMS
Amgen Inc. $29.62 05/16/2024 Food and Beverage Undisputed 01/23/2026 1117610591 CMS
Amgen Inc. $26.89 08/14/2024 Food and Beverage Undisputed 01/23/2026 1117610593 CMS
Amgen Inc. $121.65 08/20/2024 Food and Beverage Undisputed 01/23/2026 1117610597 CMS
Amgen Inc. $15.39 12/16/2024 Food and Beverage Undisputed 01/23/2026 1117610595 CMS
Astellas Pharma US Inc $22.82 06/26/2024 Food and Beverage Undisputed 01/23/2026 1139519455 CMS
Astellas Pharma US Inc $23.44 10/01/2024 Food and Beverage Undisputed 01/23/2026 1139542194 CMS
AstraZeneca Pharmaceuticals LP $15.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105686655 CMS
AstraZeneca Pharmaceuticals LP $22.85 03/11/2024 Food and Beverage Undisputed 01/23/2026 1105266080 CMS
AstraZeneca Pharmaceuticals LP $23.10 06/18/2024 Food and Beverage Undisputed 01/23/2026 1104555020 CMS
AstraZeneca Pharmaceuticals LP $17.50 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104633421 CMS
AstraZeneca Pharmaceuticals LP $24.07 07/24/2024 Food and Beverage Undisputed 01/23/2026 1105496277 CMS
AstraZeneca Pharmaceuticals LP $18.63 11/05/2024 Food and Beverage Undisputed 01/23/2026 1104522868 CMS
E.R. Squibb & Sons, L.L.C. $19.30 02/21/2024 Food and Beverage Undisputed 01/23/2026 1101561051 CMS
GlaxoSmithKline, LLC. $20.04 04/22/2024 Food and Beverage Undisputed 01/23/2026 1116699309 CMS
GlaxoSmithKline, LLC. $19.40 05/10/2024 Food and Beverage Undisputed 01/23/2026 1116625986 CMS
GlaxoSmithKline, LLC. $18.09 08/13/2024 Food and Beverage Undisputed 01/23/2026 1116476616 CMS
GlaxoSmithKline, LLC. $13.48 11/18/2024 Food and Beverage Undisputed 01/23/2026 1116278738 CMS
Lilly USA, LLC $26.84 01/02/2024 Food and Beverage Undisputed 01/23/2026 1135685505 CMS
Lilly USA, LLC $23.15 02/22/2024 Food and Beverage Undisputed 01/23/2026 1135696710 CMS
Lilly USA, LLC $25.25 03/07/2024 Food and Beverage Undisputed 01/23/2026 1135703711 CMS
Lilly USA, LLC $23.74 03/14/2024 Food and Beverage Undisputed 01/23/2026 1135703713 CMS
Lilly USA, LLC $23.66 04/11/2024 Food and Beverage Undisputed 01/23/2026 1135685507 CMS
Lilly USA, LLC $21.07 05/09/2024 Food and Beverage Undisputed 01/23/2026 1135685509 CMS
Lilly USA, LLC $25.13 08/15/2024 Food and Beverage Undisputed 01/23/2026 1135653725 CMS
Lilly USA, LLC $19.79 09/12/2024 Food and Beverage Undisputed 01/23/2026 1135685511 CMS
Lilly USA, LLC $21.48 11/06/2024 Food and Beverage Undisputed 01/23/2026 1135687584 CMS
Novo Nordisk Inc $17.27 03/28/2024 Food and Beverage Undisputed 01/23/2026 1100502565 CMS
Novo Nordisk Inc $20.00 04/18/2024 Food and Beverage Undisputed 01/23/2026 1100560049 CMS
Novo Nordisk Inc $24.35 05/30/2024 Food and Beverage Undisputed 01/23/2026 1100576128 CMS
Novo Nordisk Inc $24.61 08/19/2024 Food and Beverage Undisputed 01/23/2026 1100654991 CMS
PFIZER INC. $21.86 04/16/2024 Food and Beverage Undisputed 01/23/2026 1132004190 CMS
PFIZER INC. $21.58 07/23/2024 Food and Beverage Undisputed 01/23/2026 1132009676 CMS
Teva Pharmaceuticals USA, Inc. $7.39 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151647946 CMS
Teva Pharmaceuticals USA, Inc. $11.73 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151647948 CMS
Teva Pharmaceuticals USA, Inc. $125.01 03/19/2024 Food and Beverage Undisputed 01/23/2026 1151648170 CMS
Teva Pharmaceuticals USA, Inc. $17.99 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151648178 CMS
Teva Pharmaceuticals USA, Inc. $13.09 07/10/2024 Food and Beverage Undisputed 01/23/2026 1151648236 CMS
Teva Pharmaceuticals USA, Inc. $20.32 08/05/2024 Food and Beverage Undisputed 01/23/2026 1151648244 CMS
Teva Pharmaceuticals USA, Inc. $24.06 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151648246 CMS
Teva Pharmaceuticals USA, Inc. $13.79 09/17/2024 Food and Beverage Undisputed 01/23/2026 1151648254 CMS
Teva Pharmaceuticals USA, Inc. $19.83 10/08/2024 Food and Beverage Undisputed 01/23/2026 1151648256 CMS
Teva Pharmaceuticals USA, Inc. $22.57 11/20/2024 Food and Beverage Undisputed 01/23/2026 1151648282 CMS
Teva Pharmaceuticals USA, Inc. $14.10 12/04/2024 Food and Beverage Undisputed 01/23/2026 1151648284 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.